These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 18832042

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia.
    Schellong S, Altmann E, von Bilderling P, Rudofsky G, Waldhausen P, Rogatti W.
    Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Neutrophil function in peripheral arterial occlusive disease: the effects of prostaglandin E1.
    Weiss T, Eckstein H, Weiss C, Diehm C.
    Vasc Med; 1998 Jun; 3(3):171-5. PubMed ID: 9892509
    [Abstract] [Full Text] [Related]

  • 12. Intermittent intraarterial infusion therapy with PGE1 in patients with severe claudication--results of a randomized prospective double blind study.
    Caspary L, Creutzig A, Radeke U, Specht S, Alexander K.
    Biomed Biochim Acta; 1988 Jun; 47(10-11):S307-10. PubMed ID: 3073766
    [Abstract] [Full Text] [Related]

  • 13. Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication.
    Mangiafico RA, Messina R, Attinà T, Dell'Arte S, Giuliano L, Malatino LS.
    Angiology; 2000 Jun; 51(6):441-9. PubMed ID: 10870853
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs].
    Luzzi R, Belcaro G, Ippolito E, Dugall M, Cesarone MR, Scoccianti M, Errichi BM, Pellegrini L, Ciammaichella G, Ledda A, Ricci A, Cornelli U, Feragalli B, Hosoi M, Corsi M, Simeone E, Agus GB.
    Minerva Cardioangiol; 2012 Aug; 60(4):405-13. PubMed ID: 22858918
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: results of a multicenter placebo-controlled double-blind trial.
    Diehm C, Balzer K, Bisler H, Bulling B, Camci M, Creutzig A, Gruss JD, Horsch S, Odemar F, Piehler U, Rogatti W, Scheffler P, Spengel F, Treese N, Turowski A, Waldhausen P, Weber B, Weiss T.
    J Vasc Surg; 1997 Mar; 25(3):537-44. PubMed ID: 9081136
    [Abstract] [Full Text] [Related]

  • 20. Effects of intravenous prostaglandin E1 on arterial compliance: a randomized controlled trial.
    Mlekusch W, Schillinger M, Sabeti S, Al-Awami M, Gschwandtner M, Minar E.
    Vasa; 2004 Aug; 33(3):131-6. PubMed ID: 15461064
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.